0.8975
-0.0198
(-2.16%)
At close: 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.16 | -0.16 | -0.58 | -0.59 |
| Low Estimate | -0.16 | -0.16 | -0.58 | -0.59 |
| High Estimate | -0.16 | -0.16 | -0.58 | -0.59 |
| Year Ago EPS | -0.22 | -0.16 | -0.73 | -0.58 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.25 | -0.08 | -0.16 | -0.16 |
| EPS Actual | -0.22 | -0.16 | -0.12 | -0.23 |
| Difference | 0.03 | -0.08 | 0.04 | -0.07 |
| Surprise % | 12.00% | -100.00% | 25.00% | -43.75% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.16 | -0.16 | -0.58 | -0.59 |
| 7 Days Ago | -0.16 | -0.16 | -0.58 | -0.59 |
| 30 Days Ago | -0.16 | -0.16 | -0.58 | -0.59 |
| 60 Days Ago | -0.16 | -0.16 | -0.58 | -0.59 |
| 90 Days Ago | -0.14 | -0.14 | -0.58 | -0.59 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ENLV | 27.27% | 0.00% | 20.55% | -1.72% |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 4/3/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/24/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/3/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/7/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 12/11/2024 |
| Maintains | D. Boral Capital: Buy to Buy | 12/3/2024 |
Related Tickers
PLUR Pluri Inc.
3.8150
+2.01%
BLRX BioLineRx Ltd.
2.7500
+13.17%
BONS.TA Bonus BioGroup Ltd.
16.50
+12.24%
PYPD PolyPid Ltd.
2.4800
-0.60%
ORMP Oramed Pharmaceuticals Inc.
2.1100
-0.94%
ENTX Entera Bio Ltd.
1.6900
0.00%
NRSN NeuroSense Therapeutics Ltd.
1.0600
+8.16%
CGEN Compugen Ltd.
1.2600
+4.13%
CLGN CollPlant Biotechnologies Ltd.
2.4377
-2.10%
CANF Can-Fite BioPharma Ltd.
1.5700
+12.30%